Human Insulin Market by Product, Types & Brand -2018

MarketsandMarkets Presents

Human Insulin Market by Product, Types & Brand -2018

http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html

The “Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2018�provides a detailed overview of the major drivers,restraints, challenges, opportunities, current market trends,and strategies impacting the global human insulin market along with the estimates and forecasts of the revenue and share analysis.

Browse 112 market data tables and 43 figures spread through 250 pages and in-depth TOC on "Human Insulin Market " http://www.marketsandmarkets.com/Market-Reports/human-insulin-market229295783.html Early buyers will receive 10% customization in this report.

The global human insulin market is estimated to reach $42 billion by 2019, at a CAGR of 12.5% from 2014-2019

http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html

The human insulin market is segmented based on types of insulin, and branded drugs available in the market.

The two major classifications of human insulin are traditional and modern human insulin.

Further traditional human insulin is divided into three types- short acting, intermediate acting, and premixed traditional human insulin.

Modern human insulin is fragmented into long acting, rapid acting, and premixed modern human insulin. Of all, premixed and long acting modern human insulin will be the two fastest growing markets in the given forecast period.

Request for a Customization of the Report: http://www.marketsandmarkets.com/requestCustomization.asp?id=229295783

http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html

The biologics/branded insulin considered for this study are Apidra, Actrapid, Humalog, Humulin, Insuman, Insulatard, Lantus, Levemir, Mixtard, Novomix, Novorapid, and Tresiba.

The three biosimilars available in the Asian countries and RoW are Wosulin (Wockhardt), Basalog (Biocon), and Glaritus (Wockhardt).

In comparison to branded drugs, biosimilar, a similar version of branded biologics, will be the faster growing market in the next five years.

Among all available brands, Lantus (Insulin Glargine) accounted for the largest share in the market whereas Apidra and Levemir will be the fastest growing drugs in the forecast period.

Enquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=229295783

http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html

A major factor that propels the growth of the market is the increasing demand for biologics and biosimilars to treat diabetes. Apart from this, factors such as government initiatives, growing aging population, and high prevalence of diabetes across the globe will foster the demand of insulin. The adoption of new technologies such as safety pen needles offers huge potential opportunity for growth in the market.

North America is the largest contributor to the global human insulin market whileAsia is expected to grow at the highest rate. Asia (China, and India), Middle East (Saudi Arabia, Egypt, Qatar, U.A.E), and Latin America (Brazil, Mexico) are also poised to grow at doubledigit CAGRs in the coming years.

The key players in the market are Novo Nordisk (Denmark), Eli Lilly (U.S), Sanofi Aventis(France),Biocon (India), Julphar(U.A.E),Wockhardt (India),SemBioSys (Canada), and GSK (U.K.).

Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=229295783

http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html

About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html

Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets